ODTX Odyssey Therapeutics, Inc.
-
Odyssey Therapeutics Missed Consensus Estimates
Wednesday, August 5, 2026 · 12:00 AM ET
Odyssey Therapeutics (ODTX) reported a loss of $1.26 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.83 per share. The company missed consensus estimates by 51.81%.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($1.26)
Earnings Whisper®
—
Consensus Estimate
($0.83)
Earnings Surprise
Earnings Growth—
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—